Indonesia’s first blood plasma facility to begin operations next year - Companies - The Jakarta Post

The Karawang facility is being developed by PT SK Plasma Core Indonesia, a joint venture between South Korea's SK Plasma and Indonesia's sovereign wealth fund INA, with an investment of US$150 million.